Literature DB >> 25967457

MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.

Yidong Cheng1, Xiao Yang1, Xiaheng Deng1, Xiaolei Zhang1, Pengchao Li1, Jun Tao1, Qiang Lu2.   

Abstract

MicroRNAs (miRNAs) are recognized as important molecules and have emerged as important gene regulators in tumorigenesis. Growing evidence suggested that miR-218 was a tumor suppressor in many human cancers. However, its underlying role in bladder cancer (BCa) remains unclear. The aim of this study was to explore the effect of miR-218 on the proliferation, migration, and invasion of BCa cells. We found that miR-218 was frequently downregulated in BCa tissues compared with normal adjacent tissues. In vitro and in vivo assays demonstrated that miR-218 overexpression in the BCa cells inhibited cell proliferation, migration, and invasion. Luciferase reporter assay showed that BMI-1 was a direct target of miR-218. In addition, we found that miR-218 regulated the expression of BMI-1 and its downstream target (PTEN) and participated in the phosphorylation of AKT. Our findings indicate that miR-218 functions as tumor suppressor in BCa, and the miR-218/BMI-1 axis may provide novel diagnostic and therapeutic strategies for the treatment of BCa.

Entities:  

Keywords:  BMI-1; Bladder cancer; Invasion; MicroRNA-218; Migration; Proliferation

Mesh:

Substances:

Year:  2015        PMID: 25967457     DOI: 10.1007/s13277-015-3532-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

1.  CircRNA_28313/miR-195a/CSF1 axis modulates osteoclast differentiation to affect OVX-induced bone absorption in mice.

Authors:  Xia Chen; Zhengxiao Ouyang; Yi Shen; Bo Liu; Qiang Zhang; Lu Wan; Ziqing Yin; Wei Zhu; Shuai Li; Dan Peng
Journal:  RNA Biol       Date:  2019-06-19       Impact factor: 4.652

2.  MicroRNA-218-5p Promotes Endovascular Trophoblast Differentiation and Spiral Artery Remodeling.

Authors:  Jelena Brkić; Caroline Dunk; Jacob O'Brien; Guodong Fu; Lubna Nadeem; Yan-Ling Wang; David Rosman; Mohamed Salem; Oksana Shynlova; Issaka Yougbaré; Heyu Ni; Stephen J Lye; Chun Peng
Journal:  Mol Ther       Date:  2018-07-12       Impact factor: 11.454

3.  MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.

Authors:  Yong-Hao Nan; Jun Wang; Yao Wang; Peng-Hao Sun; Yu-Ping Han; Li Fan; Kai-Chen Wang; Fu-Jun Shen; Wei-Hua Wang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 4.  Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.

Authors:  Ulrich H Weidle; Fabian Birzele
Journal:  Cancer Diagn Progn       Date:  2021-07-03

5.  The role of microRNAs in gallbladder cancer.

Authors:  Ganghua Yang; Lei Zhang; Ruixiang Li; Lin Wang
Journal:  Mol Clin Oncol       Date:  2016-05-11

6.  MicroRNA-218 inhibits the migration, epithelial-mesenchymal transition and cancer stem cell properties of prostate cancer cells.

Authors:  Bing Guan; Lijun Mu; Linlin Zhang; Ke Wang; Juanhua Tian; Shan Xu; Xinyang Wang; Dalin He; Yuefeng Du
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

7.  [MicroRNA-218 promotes osteosarcoma cell apoptosis by down-regulating oncogene B lymphoma mouse Moloney leukemia virus insertion region 1].

Authors:  Gui-Hua Lai; Ai-Lan Huang; Zhi Zhao; Xing-Hao Lu; Wen-Xuan Zu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

8.  Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.

Authors:  Bo Liu; Yanfeng Tian; Fang Li; Zengren Zhao; Xia Jiang; Congjie Zhai; Xiaodong Han; Like Zhang
Journal:  Oncol Rep       Date:  2016-04-15       Impact factor: 3.906

9.  Expression of B cell-specific Moloney murine leukemia virus integration site 1 in vulvar squamous cell carcinoma and its effect on the biological behavior of A-431 cells.

Authors:  Xueli Bai; Ling Ouyang; B O Li; Yang Zhou; Xin Wen
Journal:  Oncol Lett       Date:  2015-09-25       Impact factor: 2.967

10.  MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.

Authors:  Yidong Cheng; Xiaolei Zhang; Peng Li; Chengdi Yang; Jinyuan Tang; Xiaheng Deng; Xiao Yang; Jun Tao; Qiang Lu; Pengchao Li
Journal:  Onco Targets Ther       Date:  2016-08-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.